PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2019-10-07

Date Title Company
07-Oct-2019 Chemistree Cancels PCCBD Investment Chemistree Technology Inc.
07-Oct-2019 vertX Bioprocess Conference Convenes Biotech and Biopharma Leaders to Accelerate Industry Collaboration Thermo Fisher Scientific
07-Oct-2019 ESSA Pharma Board of Directors Approves Stock Option Plan, RSU Plan and Option Grants ESSA Pharma Inc
07-Oct-2019 Research Shows ProChondrix® CR Maintains Consistent, High Cell Viability For Two Years AlloSource
07-Oct-2019 4SC AG resolves to issue new shares; Santo and ATS undertake to subscribe / buy the new shares 4SC AG
07-Oct-2019 Four Interactive Sessions to Take Place at the 2019 Respiratory Drug Delivery Conference SMi Group
07-Oct-2019 BiondVax Receives EUR4M From the European Investment Bank (EIB) in Support of Ongoing Universal Influenza Vaccine Pivotal Phase 3 Trial Biondvax Pharmaceuticals Ltd
07-Oct-2019 Agrios Global Holdings Ltd. Announces Dr. Curt Livesay, Director of Agronomy is Guest Columnist and Webinar Co-host at Cannabis Business Times Agrios Global Holdings Ltd.
07-Oct-2019 Bio-Techne Leverages The RNAscope(TM) Technology To Advance A Multiomic Approach To Antibody Validation Bio-Techne Corporation
07-Oct-2019 NIH Grant Awarded to Akelos Collaborator, Funds Work to Develop Non-Opioid Drugs for Neuropathic Pain Akelos Inc
07-Oct-2019 SAPPHIRE MEDICAL CLINIC - UK’S FIRST MEDICAL CANNABIS CLINIC TO BE APPROVED BY REGULATOR Sapphire Medical Clinic
07-Oct-2019 Haselmeier Signs an Exclusive Agreement with Stevanato Group to License Axis-D Pen-injector Technology and Intellectual Property for the Therapeutic Area of Diabetes Care B3C newswire
07-Oct-2019 Santhera Announces Presentation by ReveraGen of Positive 18-Month Data with Vamorolone in Duchenne Muscular Dystrophy Santhera
07-Oct-2019 Editas Medicine and MaxCyte Announce Clinical and Commercial License Agreement for Engineered Cell Medicines Editas Medicine, Inc
07-Oct-2019 Interim Financial Results for the six months ended 31 July 2019 e-therapeutics plc
07-Oct-2019 Galderma Receives FDA Approval for AKLIEF® (trifarotene) Cream, 0.005%, the First New Retinoid Molecule for the Treatment of Acne in Over 20 Years Galderma Laboratories
07-Oct-2019 Castor Announces International Expansion to Meet Growing Demand for AI-Powered Clinical Data Platform Castor
07-Oct-2019 Nordic Nanovector signs global clinical and commercial agreement with ITM for the supply of no-carrier-added Lutetium-177 Nordic Nanovector
07-Oct-2019 Keytruda Forecasted to Be the Top Drug by Annual Revenue in 2023, says GlobalData GlobalData
07-Oct-2019 Almirall takes a leap into dermatology digital health innovation Almirall